Welcome to Life Science Headlines (formerly Healthcare Headlines). As some of you know, in 2014 Jacobs Management Group launched an industry specific publication (Healthcare Sales and Marketing Magazine) featuring news, trends, industry updates, and hot innovations all centered around the Medical Device, Biotechnology, and Pharmaceutical industries. We are excited to launch Life Science Headlines on LinkedIn and invite you to subscribe to the latest updates.
Convatec to acquire Triad for up to $450M to break into Wound Biologics Deeside, UK, and Memphis, TN, January 28, 2022 (ConvaTec Group PLC) — ConvaTec Group Plc (CTEC.LN), a global medical solutions company focused on the management of chronic conditions, is pleased to announce that it has entered into a definitive agreement to acquire Triad Life Sciences Inc(1) (‘Triad’), a US-focused medical device company that develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.
LEO Pharma appoints Christophe Bourdon as new CEO Ballerup, DK, January 31, 2022 (LEO Pharma) – LEO Pharma today announced the appointment of Christophe Bourdon as new Chief Executive Officer of the company, effective April 1, 2022. Christophe Bourdon joins from Orphazyme A/S where he has held the position as CEO since April 2021, following significant global leadership roles in both Amgen and Alexion.
Smith+Nephew acquires Engage for up to $135M London, UK, January 19, 2022 (PRNewswire) — Smith+Nephew (LSE: SN,NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US.
RapidAI appoints former President and CEO of GE Healthcare Imaging, Karim Karti, as CEO San Mateo, CA, January 31, 2022 (BUSINESS WIRE) — RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and patient workflow, today announced Karim Karti, former President and CEO of GE Healthcare Imaging, as the company’s Chief Executive Officer (CEO).
Septerna Launches With $100 Million Series A Financing to Expand the Frontier of GPCR-Targeted Medicines San Francisco, CA, January 27, 2022 (Business Wire) — Septerna, Inc., a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced its launch and Series A financing of $100 million.